AEI's Scott Gottlieb argues that the focus of legislation should not be on creating employment benefits specifically targeted to H1N1, but instead on ways to mitigate risks in future pandemics by providing Americans with early vaccinations.

This volume offers a balanced and comprehensive snapshot of the changing landscape for vaccine markets.

The development of antivirals for pandemic flu provides important insights into the pharmaceutical industry's ability to advance public health.

I was initially assigned the working title, "Pursuing Equality in Health Care for the Elderly Is Futile." I prefer to think of that particular dead end of health policy as one of listening to the wrong music for too long. Hence, this article revises the title song of the movie, Urban Cowboy, to "Looking for better health [rather than either "love" or "love of equality"] in all the wrong places.

When markets are irrational, it's impossible to say what might set them off, and fear of disaster becomes a powerful excuse for policy makers to do whatever they choose.

A big government president, Obama is learning, needs to be a war president first.

The United States' insufficient supply of H1N1 vaccines to inoculate our population demonstrates how poorly prepared we are to confront a pandemic.

We must make a concerted effort today to increase our capacity for timely development of safe, effective and innovative flu vaccines.